| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/RHEUMATOLOGY/39.6.674 |
| P698 | PubMed publication ID | 10888714 |
| P2093 | author name string | Distler A | |
| Braun J | |||
| Sieper J | |||
| Neure L | |||
| Liangos O | |||
| Pauschinger M | |||
| Kühl U | |||
| Schwimmbeck PL | |||
| P2860 | cites work | Diastolic abnormalities in systemic sclerosis: evidence for associated defective cardiac functional reserve | Q33579068 |
| D-Penicillamine therapy in progressive systemic sclerosis (scleroderma): a retrospective analysis | Q34057018 | ||
| Pericardial involvement in systemic sclerosis | Q35547283 | ||
| Angiotensin converting enzyme inhibitors, left ventricular hypertrophy and fibrosis | Q36671988 | ||
| Treatment of scleroderma heart by D-penicillamine | Q36796260 | ||
| Immunohistological evidence for a chronic intramyocardial inflammatory process in dilated cardiomyopathy. | Q36830066 | ||
| Heart disease in systemic sclerosis | Q38745659 | ||
| The fibroblast-specific MAb AS02: a novel tool for detection and elimination of human fibroblasts | Q41068038 | ||
| Cardiac involvement in scleroderma | Q41220227 | ||
| Myocardial lesions of progressive systemic sclerosis. A cause of cardiac dysfunction | Q44007356 | ||
| Survival with systemic sclerosis (scleroderma). A life-table analysis of clinical and demographic factors in 309 patients | Q44686945 | ||
| Acute myocarditis in fulminant systemic sclerosis | Q45185651 | ||
| Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls | Q49051672 | ||
| Reduced coronary flow and resistance reserve in primary scleroderma myocardial disease. | Q54424370 | ||
| P433 | issue | 6 | |
| P304 | page(s) | 674-679 | |
| P577 | publication date | 2000-06-01 | |
| P1433 | published in | Rheumatology | Q7320492 |
| P1476 | title | The possible role of myocardial biopsy in systemic sclerosis. | |
| P478 | volume | 39 |
| Q41223874 | Association of immunological cell profiles with specific clinical phenotypes of scleroderma disease. |
| Q37404896 | Cardiac magnetic resonance imaging in systemic sclerosis: a cross-sectional observational study of 52 patients |
| Q36289875 | Characteristics and clinical relevance of late gadolinium enhancement in cardiac magnetic resonance in patients with systemic sclerosis |
| Q41789551 | Characteristics of interstitial fibrosis and inflammatory cell infiltration in right ventricles of systemic sclerosis-associated pulmonary arterial hypertension |
| Q35597574 | Clinical and histopathological features of patients with systemic sclerosis undergoing endomyocardial biopsy |
| Q38761664 | Consensus best practice pathway of the UK Systemic Sclerosis Study group: management of cardiac disease in systemic sclerosis |
| Q52808829 | Diagnosis and management of myocardial involvement in systemic immune-mediated diseases: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Disease. |
| Q53118185 | Life-threatening arrhythmias in a scleroderma patient: the role of myocardial inflammation in arrhythmic outburst. |
| Q24629481 | Pharmacotherapy of systemic sclerosis |
| Q42955660 | Resolution of sclerodermatous myocarditis after autologous stem cell transplantation |
| Q36358485 | Scleroderma heart disease |
| Q54977617 | Sex differences in pulmonary arterial hypertension: role of infection and autoimmunity in the pathogenesis of disease. |
| Q35689002 | The heart in systemic sclerosis |
| Q35517421 | The right ventricle in scleroderma (2013 Grover Conference Series). |
Search more.